Abstract:Background Helicobacter pyloribacterium is a major cause of gastritis. With increasing use of antibiotics to treat infections, mutation resistant strains have emerged in most human populations. To effectively treat patients to help resolve infections, the clinician needs information on the antibiotic susceptibility profile of the infection. Therefore, a rapid and accurate test is required to provide this information. To address this issue, we designed and validated a real time multiplex ARMS-PCR assay for rapid detection of highly prevalentH. pyloriclarithromycin and levofloxacin resistance mutations. The aim of the study was to evaluate the analytical and diagnostic sensitivity and specificity of ARMS-PCR, using direct Sanger sequencing of the known resistance mutations as the gold standard. Results In preliminary studies using a defined number of plasmids with clarithromycin and levofloxacin resistance mutations, the analytical sensitivity of our ARMS-PCR assay was 50 plasmid copies, equating to around 50 bacterium in a gastric biopsy sample. In terms of specificity, the assay was highly specific for the targeted resistance mutations. The assay was also able to reliably and efficiently detect heteroresistance of clarithromycin and levofloxacin mutations, even at a disproportional ratio of 1:1000. From the analysis of 192 samples with suspectedH. pyloriinfections, the diagnostic sensitivity and specificity of the assay was very high for detection of clarithromycin resistance (100% and 100%), levofloxacin resistance (98.04% and 95.04%) and clarithromycin and levofloxacin double resistance (100% and 96.91%). Amongst the 74 patients diagnosed antibiotic resistance bacteria, 23 (31.1%) had clarithromycin resistance, 21 (28.4%) had levofloxacin resistance and 30 (40.5%) had double resistance. From sample receipt to results, our single tube assay could be routinely completed in under 2 h. Conclusions Our assay demonstrated high diagnostic sensitivity and specificity for detection of clarithromycin and levofloxacin resistantH. pylori. Based on proven accuracy, together with high efficiency, scalability and low cost, our assay has useful clinical utility for rapid diagnosis of clarithromycin and levofloxacin resistantH. pyloriinfections. Our assay results will provide patients with a clear diagnosis, enabling the treating clinician to administer the most effective antibiotic regimen to help the clear the infection.

Survey of the drug resistance of helicobacter pylori to clarith romycin in Guixi area

Efficacy of quadruple therapy with clarithromycin based on faecal molecular antimicrobial susceptibility tests as first-line treatment for <i>Helicobacter pylori</i> infection: a protocol of a single-centre, single-blind, randomised clinical trial in China

Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China.

Characteristics of antibiotic resistance of Helicobacter pylori strain isolated from patients

Antibiotic Resistance of Helicobacter Pylori in Chinese Children: A Multicenter Study from 2016 to 2023.

Genotype profiles of Helicobacter pylori from gastric biopsies and strains with antimicrobial-induced resistance.

Drug resistance ofHelicobacter pyloriand related gene mutations

Prospective Multi-Region Study on Primary Antibiotic Resistance of Helicobacter Pylori Strains Isolated from Chinese Patients

Molecular Testing for H. Pylori Clarithromycin and Quinolone Resistance: a Prospective Chinese Study

Genotype profiles of from gastric biopsies and strains with antimicrobial-induced resistance

[The Prevalence and Mechanism of Helicobacter Pylori Resistance to Clarithromycin in Beijing].

Analysis of the Drug Resistance of Helicobacter Pylori in Patients with Upper Gastrointestinal Symptoms in Hexi Corridor

Clinical Analysis of Resistance of Hp Isolates to Five Antibiotics

Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype

Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter retrospective study over 7 years.

Mutations in the Antibiotic Target Genes Related to Clarithromycin, Metronidazole and Levofloxacin Resistance in Helicobacter Pylori Strains from Children in China

Microarray-Based Detection and Clinical Evaluation for Helicobacter pylori Resistance to Clarithromycin or Levofloxacin and the Genotype of CYP2C19 in 1083 Patients

Phenotype and Molecular Detection of Clarithromycin and Levofloxacin Resistance in Helicobacter Pylori Clinical Isolates in Beijing

Evaluation of Multiplex ARMS-PCR for Detection Ofhelicobacter Pylorimutations Conferring Resistance to Clarithromycin and Levofloxacin

Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori

Primary Antibiotic Resistance of Helicobacter Pylori in Chinese Patients: a Multiregion Prospective 7-Year Study.